BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260501
DTEND;VALUE=DATE:20260503
DTSTAMP:20260828T054205
CREATED:20260225T143735Z
LAST-MODIFIED:20260225T143735Z
UID:100118906-1777593600-1777766399@www.pathologynews.com
SUMMARY:2026 Digital Pathology Course
DESCRIPTION:0000Days00Hrs00Min00SecDigital pathology is rapidly emerging as a new standard of care\, enabling the scanning\, review\, and storage of pathology slides in a fully digital format. These digital workflows enhance patient care through rapid\, reliable image retrieval; support remote review and telepathology; enable the use of computational and AI-assisted tools; and facilitate seamless sharing of cases for consultation\, collaboration\, and education. \nMemorial Sloan Kettering Cancer Center (MSK) has been a leader in digital pathology adoption since 2006 and has digitized more than 10 million slides across multiple platforms. The operational expertise and real-world lessons learned at MSK provide a practical roadmap for institutions seeking to implement or expand digital pathology programs. \nThis two-day\, in-person course\, presented by the MSK Department of Pathology and Laboratory Medicine in collaboration with the Digital Pathology Association (DPA)\, will provide participants the opportunity to learn of new advances in the field as well as engage with other pathologists and researchers in field. \nObjectives\n\nDescribe digital pathology history and integration in pathology practice\nExplain the validation process required for clinical grade digital pathology\nDiscuss digital pathology role in clinical\, educational and research use cases\nSurvey the digital pathology laboratory facilities and view digital tools used in the digital workflows\nRecognize the financial cost of digital pathology implementation\n\nRegister NowProgram Highlights\n\n\n\nPresentations and interactive discussions facilitated by MSK faculty on the practical implementation of digital pathology\, including infrastructure design\, workflow validation\, regulatory considerations\, AI-enabled tools\, and operational and financial planning.\nAn interactive panel discussion\, featuring digital pathology leaders from Memorial Sloan Kettering Cancer Center\, NewYork-Presbyterian Hospital / Weill Cornell Medicine\, Mount Sinai Health System\, Northwell Health\, and NYU Langone Health.\nOptional guided tour and live demonstration of the MSK Digital Pathology Laboratory highlighting high-volume scanning operations and preanalytical workflow modifications (limited to 60 participants).\nAn introduction to the Digital Pathology Association.\nComplimentary networking reception on Friday evening\, providing an opportunity for discussion and professional connections.\nAn online syllabus will be made available to all attendees following the course and will include select PDFs of faculty presentation slides.\n\n\n\nThis activity is designed for pathologists and researchers interested in large-scale digital pathology operations and the clinical implementation of digital pathology and AI-enabled tools.
URL:https://www.pathologynews.com/event/2026-digital-pathology-course/
LOCATION:Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/2026-Digital-Pathology-Course.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260505T160000
DTEND;TZID=Europe/London:20260505T170000
DTSTAMP:20260828T054205
CREATED:20260330T083139Z
LAST-MODIFIED:20260330T083139Z
UID:100119976-1777996800-1778000400@www.pathologynews.com
SUMMARY:Advancing Precision Medicine Through Pathology and AI-Powered CDx with Indica Labs
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 8:00 PDT\, 11:00 EDT\, 16:00 BST \nLearn about Indica Labs’ ability to deliver AI-driven CDx\n\n\nSummary\n\n\n\n\nJoin Indica Labs for an exciting webinar on developing AI-powered companion diagnostics in digital pathology. In this comprehensive session\, Indica Labs will introduce its vision for transforming bench to bedside to bench workflows\, take a deep dive into our experience in AI image analysis\, and demonstrate its ability to bring diagnostic products to market. Along the way\, you’ll learn about our experience conducting early proof-of-concept studies\, advancing them to biomarker discovery\, and managing clinical trial assays.   \nDon’t miss this opportunity to hear from senior executives as well as the CEO and Founder of Indica Labs on the topic of developing AI-driven companion diagnostics.  \n\n\nLearning Objectives\n\nLearn about Indica Labs’ initiatives and strategy for developing AI-powered CDx products in digital pathology\nGain insight into Indica Labs’ strategic partnership with Leica Biosystems\nDiscover how Indica Labs can take AI-based early proof-of–concept studies all the way through the development lifecycle to become a regulatory approved CDx\nFind out about deployment options in the CE-IVDR HALO AP® platform\nUnderstand the pathway to regulatory approval for CDx co-developed with Indica Labs and options for additional strategic partnerships\n\nHALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe\, the UK\, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition\, HALO AP® provides built-in compliance with FDA 21 CFR Part 11\, HIPAA\, and GDPR. \nRegister Now\nPresenters\n\nSteven Hashagen \nCEO and Founder\nIndica Labs  \nSteven Hashagen is the founder and CEO of Indica Labs\, a leading digital pathology software and AI company. Prior to forming Indica Labs in 2011\, Steven held software engineering\, software architect\, and product management roles at Aperio Technologies. Through this combined experience Steven has been a pioneer in the digital pathology field for over 20 years.  \nPeter Caie\, PhD\nSr. Director\, Precision Medicine\nIndica Labs \nPeter Caie worked for 9 years as a Senior Scientist at AstraZeneca before completing his PhD from the University of Edinburgh in Cancer Pathology. He went on to run the Quantitative and Digital Pathology (QUAD) Lab at the University of St Andrews where his research focused on artificial intelligence\, cancer prognosis and diagnosis in the field of digital and molecular pathology. Currently\, Dr. Caie is a Senior Director at Indica Labs where he manages the development of commercial AI products\, including CDx assays\, designed for deployment in both the clinical and life science fields.  \nDoug Bowman (Moderator)\nVP Precision Medicine\nIndica Labs  \nDoug is responsible for Indica Labs’ Precision Medicine group that partners with pharma companies to bring new AI-powered companion diagnostics to market. His team leads the commercial development of clinical AI solutions that deploy in HALO AP® and span laboratory operations to clinical research and diagnostic use cases. His Pharma Services team\, with deep experience in quantitative image analysis services\, supports customers’ pre-clinical and clinical biomarker assays. Prior to Indica Labs\, he spent 12+ years at Takeda Pharmaceuticals where he led the tissue-based imaging capabilities to support early discovery\, translational\, and clinical programs. Doug has a BSE in biomedical and electrical engineering from Duke University. 
URL:https://www.pathologynews.com/event/advancing-precision-medicine-through-pathology-and-ai-powered-cdx-with-indica-labs/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/Advancing-Precision-Medicine-Through-Pathology-and-AI-Powered-CDx-with-Indica-Labs.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260509
DTSTAMP:20260828T054205
CREATED:20260107T111116Z
LAST-MODIFIED:20260220T111555Z
UID:100117724-1778112000-1778284799@www.pathologynews.com
SUMMARY:The Digital Pathology & AI Congress USA and American Spatial Biology Congress 2026
DESCRIPTION:0000Days00Hrs00Min00SecOPEN LETTER:\nANIL PARWANI Professor of Pathology and Biomedical Informatics\, Chair of Pathology Department\, The Ohio State University \nDear Colleagues\, \nIt is my great pleasure to offer my full support for the 12th Digital Pathology & AI Congress\, co-located with the 3rd American Spatial Biology Congress\, taking place on May 7–8\, 2026 in Columbus\, Ohio. \nWe are at a defining moment in the evolution of pathology. Digital pathology and artificial intelligence are no longer future concepts—they are actively reshaping how we diagnose disease\, generate knowledge from tissues\, and deliver precision medicine to patients. When combined with advances in spatial biology\, these technologies provide unprecedented insight into tissue architecture\, cellular interactions\, and disease biology across scales. \nAt The Ohio State University\, we have witnessed firsthand how digital pathology and AI can transform clinical workflows\, enable computational discovery\, and bridge research and patient care. From whole-slide imaging and AI-assisted diagnostics to spatial multi-omics and translational research\, these tools are redefining what is possible in modern pathology. Importantly\, their successful adoption depends not only on technological innovation\, but also on collaboration\, shared learning\, and open dialogue across academia\, healthcare\, and industry. \nThis Congress brings together exactly that community. By uniting pathologists\, scientists\, clinicians\, computational experts\, and technology innovators\, the meeting provides a vital forum to explore real-world implementation\, regulatory considerations\, and emerging scientific applications. The co-location of digital pathology and spatial biology is particularly timely\, reflecting how closely these disciplines are converging to drive the next generation of precision diagnostics and therapeutics. \nI am especially pleased that this meeting is being held in Columbus and in collaboration with The Ohio State University. It offers a unique opportunity to engage with leaders while showcasing how integrated digital and spatial approaches are being applied in both research and clinical settings. \nI look forward to participating in the Congress and to delivering the keynote address\, “Journey to Precision Pathology: The Role of Digital Pathology and AI.” I strongly encourage colleagues across pathology\, biomedical research\, and industry to join us for what promises to be an impactful and forward-looking event. \nI hope to see you in Columbus in May 2026. \nAnil Parwani \nRegister Here
URL:https://www.pathologynews.com/event/the-digital-pathology-ai-congress-usa-and-american-spatial-biology-congress-2026/
LOCATION:Columbus\, Ohio\, Columbus\, OH\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/The-Digital-Pathology-AI-Congress-USA-and-American-Spatial-Biology-Congress-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260511T140000
DTEND;TZID=UTC:20260511T150000
DTSTAMP:20260828T054205
CREATED:20260423T092530Z
LAST-MODIFIED:20260423T092530Z
UID:100120535-1778508000-1778511600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Computational Pathology for Discovering Biomarkers of Immunotherapy Response in Advanced Melanoma
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Mark Schuiveling from UMC Utrecht\, the Netherlands. \nAbstract\nImmune checkpoint inhibition (ICI) has significantly improved outcomes for patients with advanced cutaneous melanoma\, leading to durable responses and potential long-term remission in approximately half of patients. However\, it is also associated with severe and sometimes irreversible toxicity\, underscoring the need for reliable biomarkers. In our group\, we investigate whether computational pathology approaches add value beyond clinical data for identifying biomarkers associated with treatment response in these patients. In this talk\, I will highlight our work on tumor-infiltrating lymphocytes in melanoma histopathology\, as well as our recent work in the PUMA challenge\, where we assessed whether additional immune cell subsets provide further associated predictive value. \nRegister NowBio\nMark Schuiveling is a medical doctor and PhD candidate at the University Medical Centre Utrecht\, the Netherlands. He is expected to defend his thesis in the summer of 2026 and is currently working as an internal medicine resident\, after which he will begin an oncology fellowship in 2027. His research focuses on melanoma\, in which he and his colleagues have assembled a multicentre dataset of digitized whole-slide images\, CT scans\, and clinical data\, with the aim of improving prediction of response to first-line immune checkpoint inhibition in patients with advanced melanoma. His work has primarily focused on histopathological analysis\, including tumor-infiltrating lymphocyte (TIL) assessment\, as well as on the organization of the PUMA challenge\, which investigated whether additional immune cell subtypes provide added predictive value.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-computational-pathology-for-discovering-biomarkers-of-immunotherapy-response-in-advanced-melanoma/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/04/TIA-Centre-Seminar-Series-Computational-Pathology-for-Discovering-Biomarkers-of-Immunotherapy-Response-in-Advanced-Melanoma.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260514T090000
DTEND;TZID=UTC:20260514T170000
DTSTAMP:20260828T054205
CREATED:20251010T103127Z
LAST-MODIFIED:20260317T221923Z
UID:100116017-1778749200-1778778000@www.pathologynews.com
SUMMARY:Edinburgh: Transforming Digital Pathology & AI: The Path Forward
DESCRIPTION:0000Days00Hrs00Min00SecThis event that brings together researchers\, clinicians and industry specialists to examine the current and emerging role of digital pathology and artificial intelligence in diagnostic practice. \nRecent developments in whole slide imaging\, computational pathology and AI-based analysis are reshaping diagnostic practice and research. This programme brings together methodological\, translational and clinical perspectives to examine how these approaches are being developed\, validated and introduced into routine pathology workflows. \nThe conference will focus on the practical realities of implementation\, including digital infrastructure\, regulatory requirements\, model validation and workforce readiness. Sessions will address how healthcare systems are managing adoption at scale\, and what is needed to move from pilot studies to reliable clinical use. \nEthical\, legal and governance issues form a core part of the programme\, with dedicated discussion on transparency\, accountability and responsibility in AI-supported diagnosis. \n\n\nWhat to expect\n\n\n\n\n\nCase studies and presentations from the experts on applications of AI in digital pathology\n8 CPD Points\nLive interaction with senior speakers\nPanel discussions\nExhibition\nAgenda geared towards networking and close collaboration\n1-2-1 Partnering Meetings\nKeynote across a sit down breakfast\nHands-on product/software demos from the industry’s leading tech providers\nEvening drinks reception and canapés\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/edinburgh-transforming-digital-pathology-ai-the-path-forward/
LOCATION:Scottish Gas Murrayfield Stadium\, Edinburgh\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/Edinburgh-Transforming-Digital-Pathology-AI-The-Path.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260518
DTEND;VALUE=DATE:20260522
DTSTAMP:20260828T054205
CREATED:20260106T145515Z
LAST-MODIFIED:20260106T145515Z
UID:100117704-1779062400-1779407999@www.pathologynews.com
SUMMARY:Association of Pathology Informatics (API) Summit 2026
DESCRIPTION:0000Days00Hrs00Min00SecWhat is the API Summit?\nThe API Summit continues its proud tradition of convening the foremost thought leaders and innovators in clinical laboratory and anatomic pathology informatics. \nEach year\, the Summit offers a comprehensive program of forward-thinking sessions across disciplines\, including:\n• Laboratory Medicine\n• Anatomic Pathology\n• Digital Imaging and Machine Vision\n• Molecular and Genomic Pathology\n• Operations and Business Analytics\n• Education and Training\n• Artificial Intelligence and Machine Learning\n• Regulatory Issues and Standards\n• And much more… \nAs digital pathology advances and laboratory-driven precision medicine transforms clinical practice\, pathology informatics has become the central nervous system of modern healthcare. It governs how diagnostic data is generated\, analyzed\, and shared—directly shaping the flow of patients through the therapeutic process. From the moment a specimen is collected to the initiation of a targeted treatment plan\, informatics ensures that information moves accurately\, securely\, and efficiently. The efficiency of this flow is essential to quality\, impacting everything from diagnostic turnaround time to clinical decision-making and patient outcomes. \nRegister NowTarget Audience\nPhysicians\, Physician Assistants\, Administrators\, House Officers\, Medical Students\, Technicians\, and Other Healthcare Professionals \nGeneral Conference Objectives\n• Define the rapidly evolving field of Digital Pathology and explore opportunities for accelerated adoption of new workflow models leveraging machine learning\, artificial intelligence\, and integrated hardware solutions.\n• Discuss foundational principles of business analytics\, computational pathology\, and AI integration to support diagnostic excellence and operational efficiency.\n• Identify and evaluate software and hardware innovations through direct engagement with leading exhibitors.\n• Recognize the technical\, regulatory\, and organizational requirements to successfully deploy informatics solutions in the clinical diagnostic environment.\n• Present new research and scientific innovations in pathology informatics through competitive abstract sessions.\n• Provide fundamental informatics education for residents and fellows.\n• Deliver updated best practices in digital pathology validation and primary diagnosis.\n• Explore methods to deploy and sustain large language models (LLMs) for clinical\, educational\, and research use. \nLearning Outcomes\nAfter completing this activity\, participants will be able to:\n1. Identify key trends in data science as applied to digital pathology and laboratory medicine.\n2. Create new opportunities for data management\, interoperability\, and collaboration within healthcare enterprises\n3. Strengthen their clinical informatics and operational efficiency competencies.\n4. Initiate machine learning and AI tool development in their departments or divisions.\n5. Identify and foster mentorship opportunities in pathology informatics.\n6. Develop and expand research collaborations that drive innovation and precision diagnostics.\n7. Understand how informatics-driven patient flow enhances the quality and timeliness of diagnosis and treatment.
URL:https://www.pathologynews.com/event/association-of-pathology-informatics-api-summit-2026/
LOCATION:Renaissance Minneapolis Hotel\, The Depot\, Minneapolis\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/Association-of-Pathology-Informatics-API-Summit-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260828T054205
CREATED:20260305T112346Z
LAST-MODIFIED:20260305T112346Z
UID:100119129-1779148800-1779407999@www.pathologynews.com
SUMMARY:HIMSS Europe 2026
DESCRIPTION:0000Days00Hrs00Min00Sec\n\nEXPERT INSIGHTS\, EXCEPTIONAL IMPACT\n\n\n\n\nHIMSS26 Europe is more than just a conference—it’s a movement toward smarter\, more efficient healthcare. Whether you’re looking to understand emerging tech trends\, improve your organization’s digital readiness\, or discover real-world applications of health IT\, HIMSS26 Europe puts you at the center of healthcare’s digital evolution.\n\n\n\n\nWhether you’re a healthcare provider\, technology innovator\, policy maker or business leader\, HIMSS26 Europe is your gateway to the latest insights on how digital transformation is revolutionizing patient care\, operational efficiency and overall health outcomes. Don’t miss our visionary keynotes\, hands-on workshops and unparalleled networking opportunities. \nIn Copenhagen\, we’ll explore the latest trends\, solutions and strategies in health tech. With insightful keynotes\, hands-on workshops and unparalleled networking opportunities\, this event is designed to accelerate your understanding of digital maturity in healthcare—and how you can leverage it to stay ahead of the curve. \n\n\nWhy attend:\n\nExplore Groundbreaking Innovations\nHear from Global Experts\nMake New Connections\nGain Actionable Insights\n\nRegister Now
URL:https://www.pathologynews.com/event/himss-europe-2026/
LOCATION:Bella Center\, Copenhagen\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/webp:https://www.pathologynews.com/wp-content/uploads/2026/03/HIMSS-Europe-2026.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260519T150000
DTEND;TZID=Europe/London:20260519T160000
DTSTAMP:20260828T054205
CREATED:20260427T102432Z
LAST-MODIFIED:20260427T151942Z
UID:100120617-1779202800-1779206400@www.pathologynews.com
SUMMARY:NPIC Digital Pathology Webinar Series - Innovation into Practice – NPIC Overview and Laboratory Implementation.​
DESCRIPTION:0000Days00Hrs00Min00SecThe National Pathology Imaging Co-Operative (NPIC)continues an exciting new series of free educational webinars on digital pathology topics. \n\nLearn first-hand about hot topics in clinical digital reporting\, the digital laboratory\, IT and informatics and get a chance to pose your questions to the experts! ​\nSuitable for pathologists\, biomedical scientists\, informatics and IT professionals\, managers and industry representatives.​\n\n​In this session:​​ \n\nGet an update of the NPIC national digital pathology PACS system in the NHS and the associated NPIC Secure Data Environment.​\nFind out how you can join NPIC and get involved.​\nLearn about digital implementation in the laboratory\, including practical considerations and tips for successful deployment.\n\nRegister NowPresenters\nProf Darren Treanor\nNPIC Programme Director\nNPIC\n\nShamila Jabbar\nNPIC Lead Biomedical Scientist\nNPIC\n\n\nDr Bethany Williams\nNPIC Knowledge and Skills Lead\nNPIC
URL:https://www.pathologynews.com/event/npic-digital-pathology-webinar-series-innovation-into-practice-npic-overview-and-laboratory-implementation/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/04/ChatGPT-Image-Apr-27-2026-at-03_31_22-PM.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260519T150000
DTEND;TZID=Europe/London:20260519T160000
DTSTAMP:20260828T054205
CREATED:20260507T084648Z
LAST-MODIFIED:20260514T082723Z
UID:100121016-1779202800-1779206400@www.pathologynews.com
SUMMARY:Two-part Webinar Series: Human Brilliance\, Augmented: Mastering Medical Information Overload with RAG and Second Brains. - Part 1
DESCRIPTION:0000Days00Hrs00Min00SecThis webinar will start at 3pm BST\, 10am EST \nIn this two-part webinar series\, Dr Soufiane Azdad and Dr Matthew Cecchini explore how AI is not here to replace the pathologist\, but to act as a powerful tool that augments human brilliance. \nEpisode 1 – The Cognitive Copilot: Taming Information Overload\nPart 1 – The Problem: Information Overload in Medicine \nThe exponential growth of medical literature\, complex classification updates\, and the cognitive load on practicing pathologists. Why generic LLMs fall short in clinical settings — hallucinations\, lack of source grounding\, and insufficient reliability for medical decision-making. \nPart 2 – Grounded AI: Retrieval-Augmented Generation at Scale \nPathology Outlines \nMyPathologyReport.com Osler \nBrief overview of NotebookLM as an accessible entry point for source-grounded AI. \nPart 3 – The Second Brain: Building a Living Knowledge Ecosystem \nThe second brain concept: moving beyond simple PDF querying to a comprehensive\, interconnected knowledge graph linking diagnoses\, IHC panels\, molecular testing\, and case notes. \nDemo of the daily workflow — capturing\, linking\, and retrieving knowledge at the point of need. \nLLM-KB-Wiki: the emerging approach (inspired by Andrej Karpathy) of giving an LLM the structured index of your knowledge base rather than traditional RAG. \nLocal LLM deployment via Ollama on Mac Studio (M4 Max\, 128GB) — guaranteed patient privacy\, zero-cost inference. \nMulti-agent systems interacting with customized wikis as a tailored diagnostic co-pilot. \n*All sessions will be presented in English. \nRegister NowSpeakers\nDr Soufiane Akdad & Dr Matthew Cecchini
URL:https://www.pathologynews.com/event/two-part-webinar-series-human-brilliance-augmented-mastering-medical-information-overload-with-rag-and-second-brains-part-1/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/05/Two-part-Webinar-Series-Human-Brilliance-Augmented-Mastering-Medical-Information-Overload-with-RAG-and-Second-Brains.-–-Part-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260519T160000
DTEND;TZID=Europe/London:20260519T170000
DTSTAMP:20260828T054205
CREATED:20260416T093638Z
LAST-MODIFIED:20260416T093638Z
UID:100120336-1779206400-1779210000@www.pathologynews.com
SUMMARY:Masterclass: Performing Spatial Analysis Workflows with HALO®
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar will start at 8:00 PDT\, 11:00 EDT\, 16:00 BST \nLearn how to unlock deeper insights and enhance your data using the HALO Spatial Analysis module\nSummary\nThe HALO® Spatial Analysis module enables quantitative assessment of cellular spatial relationships within whole-slide images\, providing a clear and reproducible way to study spatial biology in brightfield and fluorescence tissue images and supporting richer\, more informative data outputs. Join Indica Labs for a masterclass exploring the key steps in a spatial analysis workflow: validating object data\, defining biologically relevant cell populations via filtering\, and generating interactive spatial plots. David Cordover\, Field Applications Scientist\, will discuss the algorithms included in the module—nearest neighbor\, proximity\, infiltration\, and density heatmaps—and demonstrate how they enable users to measure cell–cell distances\, assess spatial proximity within defined radii\, quantify cellular infiltration across tissue interfaces\, and visualize regional cell density patterns. \nDavid will also explore the Spatial Analysis module’s data visualization capabilities\, including customizable plot layers\, histograms\, color‑scaled heatmaps\, and markup images\, and walk through how they support both quality control and biological interpretation. Advanced features for saving and reusing spatial analysis settings\, batch processing across studies\, and exporting detailed summary metrics\, object‑level data\, plots\, and reports for downstream statistical analysis will also be highlighted. \n\n\nLearning Objectives\n\n\n\n\n\nLearn how to prepare and use cell and object data for spatial analysis in HALO \nRun and understand key spatial analysis tools\, including nearest neighbor\, proximity\, infiltration\, and density heatmaps\nView and adjust spatial results using plots and markup images \nRun analyses on multiple images\, save settings\, and export results for further use \n\n\n\nRegister Now\nPresenter\n\nDavid Cordover \nField Applications Scientist \nIndica Labs  \nDavid Cordover is a research field scientist with over 20 years of experience supporting research in large biopharma\, biotech\, and CRO organizations. His career spans roles at AMGEN\, Takeda\, Akoya Biosciences\, and small CRO’s specializing in histology and digital pathology. For most of his career he has focused on AI‑ and ML‑driven image analysis\, digital pathology\, and quantitative biomarker discovery. David has led high‑impact biomarker programs from preclinical research through IND stages\, working with multiple image analysis platforms and whole‑slide scanners\, including HALO AI\, Visiopharm\, and Akoya technologies. 
URL:https://www.pathologynews.com/event/masterclass-performing-spatial-analysis-workflows-with-halo/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/04/Masterclass-Performing-Spatial-Analysis-Workflows-with-HALO®.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260520T080000
DTEND;TZID=UTC:20260521T180000
DTSTAMP:20260828T054205
CREATED:20260210T161306Z
LAST-MODIFIED:20260211T103803Z
UID:100118690-1779264000-1779386400@www.pathologynews.com
SUMMARY:In Situ Hybridisation and Spatial Omics 2026
DESCRIPTION:0000Days00Hrs00Min00SecJoin Cancer Research UK Cambridge Institute for a two-day symposium exploring the latest advances in in situ hybridisation and spatial omics – technologies that are transforming our understanding of cellular architecture\, gene expression\, and tissue microenvironments. \nSessions:\n\nAdvancing In Situ Hybridisation Technologies\nISH in Disease Diagnostics and Therapeutics\n3D Models and ISH in Complex Biological Systems\nThe Future of Spatial Biology: Integrating ISH with Multiomics and AI\n\nRegister Now
URL:https://www.pathologynews.com/event/in-situ-hybridisation-and-spatial-omics-2026/
LOCATION:Cancer Research UK Cambridge Institute\, Robinson Way\, Cambridge\, CB2 0RE\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/02/In-Situ-Hybridisation-and-Spatial-Omics.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260527
DTEND;VALUE=DATE:20260529
DTSTAMP:20260828T054205
CREATED:20260108T164332Z
LAST-MODIFIED:20260317T222429Z
UID:100117778-1779840000-1780012799@www.pathologynews.com
SUMMARY:International Spatial Biology Congress 2026
DESCRIPTION:0000Days00Hrs00Min00SecIn this rapidly developing field\, spatial biology provides significant potential for creating novel clinical insights. Recent technological advancements in spatial biology have provided insights into new strategies to prevent and treat disease\, particularly the interactions between the tumor and the tumor microenvironment in cancers to target patients to more specific treatments. New spatial research is focusing more on spatial omics integration\, spatial metabolomics becoming more prominent\, how to tackle spatial data analysis and benchmarking\, and the applications of AI within spatial biology. \nThe conference is structured around three core areas\, Spatial Multiomics Studies and Techniques\, Bioinformatics and Computational Tools for Spatial Data Analysis and Applications of Spatial Biology in Disease and Drug Development. There is an expanded focus on data analysis in response to delegate feedback. Sessions place particular emphasis on understanding\, analysing\, and standardising spatial data\, alongside advances in subcellular and spatial–temporal biology. As the field moves beyond broad molecular mapping\, talks now explore finer-scale perspectives\, including three-dimensional interactions and the dynamic behaviour of molecules within cells and tissues. \nThe programme highlights both technological innovation and the expanding application of spatial biology beyond oncology. Topics include the integration of spatial biology with mass spectrometry\, enabling detailed proteomic analysis at the subcellular level\, as well as emerging approaches in spatial transcriptomics\, epigenomics\, and metabolomics. Case studies span rare skin disease\, neuroscience\, neurodegeneration\, and cardiovascular disease\, supported by increasing engagement from the pharmaceutical sector. A strong keynote lineup brings together leading academic and industry experts to offer insight into the future direction of the field. \nRegister Now
URL:https://www.pathologynews.com/event/international-spatial-biology-congress-2026/
LOCATION:Rotterdam\, The Netherlands\, Rotterdam\, Netherlands
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/01/International-Spatial-Biology-Congress-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260529
DTEND;VALUE=DATE:20260603
DTSTAMP:20260828T054205
CREATED:20260505T110634Z
LAST-MODIFIED:20260505T110634Z
UID:100120917-1780012800-1780444799@www.pathologynews.com
SUMMARY:ASCO 2026
DESCRIPTION:0000Days00Hrs00Min00SecThe 2026 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Eric Small’s Presidential theme\, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide. For a quick guide of sessions view the “Sessions at a Glance” (schedule as of April 22\, 2026). \nYour all-access pass to the most clinically relevant cancer science. \n#ASCO26 session highlights include: \n\nPlenary Session\, featuring the meeting’s most practice-changing and clinically relevant abstract presentations and discussions\nOpening Session\, featuring the Presidential Address and Karnofsky Award and Lecture\nASCO Voices\n23 Oral Abstract Sessions\, 25 Rapid Oral Abstract Sessions\, and 13 Clinical Science Symposia\, featuring over 450 oral abstract presentations\n15 Case-Based Panels\, featuring interactive audience polling\nJoint Sessions with AACR\, ASPO\, and ECO\nOver 2\,700 Poster presentations\, including Trials in Progress\n\nRegister Now
URL:https://www.pathologynews.com/event/asco-2026/
LOCATION:McCormick Place\, Chicago\, Chicago\, IL\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/05/ASCO-2026.jpg
END:VEVENT
END:VCALENDAR